XPOVIO® is the first XPO1 inhibitor approved in Taiwan for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM). After the mainland of China, South Korea, Australia and ...

This isn’t Google’s first foray into the face-as-a-cursor space. It previously made an open-source AI accessibility tool for Windows games called Project Gameface, which was also announced for ...